StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie recorded Litigation Accrual Reserve ($M) ($M)

Form 10-Q / 10-K Legal Proceedings & Contingencies Note

QuarterlyAnnual
Latest, Q2 2026
1,700
Period ended Jun 30, 2026
Change on a year earlier
-5.6%
1,800 in Q2 2025
History
9 quarters
Since Q4 2023
Sources
8
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRecorded Litigation Accrual Reserve ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20261,700-5.6%Form 10-Q (filed 2026-08-03) ↗
Q1 2026Mar 31, 20261,700-5.6%Form 10-Q (filed 2026-05-08) ↗
Q4 2025Dec 31, 20251,600-36.0%Form 10-Q (filed 2026-08-03) ↗
Q3 2025Sep 30, 20251,500-37.5%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 20251,800–Form 10-Q (filed 2025-08-04) ↗
Q1 2025Mar 31, 20251,800–Form 10-Q (filed 2025-05-09) ↗
Q4 2024Dec 31, 20242,500+25.0%Form 10-K (filed 2026-02-20) ↗
Q3 2024Sep 30, 20242,400–Form 10-Q (filed 2024-11-04) ↗
Q4 2023Dec 31, 20232,000–Form 10-K (filed 2025-02-14) ↗

Breakdown

What makes up recorded litigation accrual reserve ($m)

Cite this data

StockData. (2026). AbbVie Recorded Litigation Accrual Reserve ($M) ($M), quarterly Q4 2023–Q2 2026 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/lit_reserve_tot

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.